5-Amino-1MQ vs Cagrilintide
5-Amino-1MQ and Cagrilintide are both studied in weight research, but they are different classes of compound with different reported research applications.
✓ both US-made · third-party tested · batch COA on every order
Last updated August 25, 2026
How do 5-Amino-1MQ and Cagrilintide differ?
5-Amino-1MQ (Small-molecule enzyme inhibitor (not a peptide)) is catalogued under weight & metabolic research; Cagrilintide (Long-acting amylin analog peptide) is catalogued under weight & metabolic research. Verve lists 5 reported research applications for 5-Amino-1MQ and 5 for Cagrilintide. Both are made in the United States, screened by HPLC to a 99%+ purity standard, and shipped with a batch-level certificate of analysis.
| field | 5-Amino-1MQ | Cagrilintide |
|---|---|---|
| compound class | Small-molecule enzyme inhibitor (not a peptide) | Long-acting amylin analog peptide |
| research area | weight & metabolic | weight & metabolic |
| reported research applications | 5 listed | 5 listed |
| supplied as | single compound | single compound |
| catalog sizes | 10mg | 10mg |
| purity standard | 99%+ by HPLC | 99%+ by HPLC |
| manufactured | United States | United States |
| batch COA | published per lot | published per lot |
| endotoxin-tested option | not offered | not offered |
| co-formulated together in | not co-formulated | not co-formulated |
| price from | $114.49 | $157.49 |
| availability | in stock | out of stock |
Prices and stock read live from the catalog. Both compounds are supplied strictly as reference materials for in-vitro laboratory research.
What is 5-Amino-1MQ and what is Cagrilintide?
5-Amino-1MQ is classified as Small-molecule enzyme inhibitor (not a peptide); Cagrilintide as Long-acting amylin analog peptide. Both profiles below cover scientific identity only — what the molecule is and which laboratory models it appears in. Verve supplies both strictly as in-vitro reference materials, and neither profile describes human or veterinary use.
5-Amino-1MQ
Small-molecule enzyme inhibitor (not a peptide)
5-Amino-1MQ is a small molecule rather than a peptide: a methylquinolinium compound that acts as a selective inhibitor of nicotinamide N-methyltransferase (NNMT). It is cell-permeable and carries a permanent positive charge on its quaternary nitrogen, a structural feature that shapes how it distributes in cellular assays and why it is used as a tool compound in enzyme-inhibition research.
full 5-Amino-1MQ profile →Cagrilintide
Long-acting amylin analog peptide
Cagrilintide is a synthetic long-acting analog of amylin, the pancreatic peptide co-secreted with insulin from beta cells. Its sequence is engineered for solubility and resistance to aggregation, and it carries a fatty-acid side chain that extends circulating half-life in pre-clinical systems, giving researchers a stable tool compound where native amylin is notoriously difficult to work with.
full Cagrilintide profile →Which research models is each compound studied in?
5-Amino-1MQ and Cagrilintide both sit inside weight & metabolic research, so their listed models share framing while differing in specifics. The table lists 5 reported research applications for 5-Amino-1MQ and 5 for Cagrilintide. Rows are per compound, not equivalences.
| 5-Amino-1MQ — reported research applications | Cagrilintide — reported research applications |
|---|---|
| NNMT enzyme-inhibition and kinetics research | Amylin- and calcitonin-receptor agonism research |
| NAD+ salvage-pathway and nicotinamide-metabolism studies | Calcitonin-receptor / RAMP complex pharmacology studies |
| S-adenosylmethionine and methyl-donor balance research | Peptide aggregation, solubility, and stability research |
| Adipocyte and cellular energy-metabolism research models | Metabolic-signaling research models |
| Small-molecule structure–activity and selectivity studies | Comparative studies alongside incretin-receptor reference compounds |
Research contexts only. Both compounds are supplied for laboratory research use only, and no entry above describes an effect in humans or animals.
What sizes and prices does verve list for 5-Amino-1MQ and Cagrilintide?
5-Amino-1MQ is listed from $114.49 and Cagrilintide from $157.49. The table below is every catalog size verve currently lists for the two compounds, at single-vial prices before the automatic multi-compound discount. Sizes describe the vial format supplied to the laboratory, nothing more.
| compound | size listed | price | availability |
|---|---|---|---|
| 5-Amino-1MQ | 10mg | $114.49 | in stock |
| Cagrilintide | 10mg | $157.49 | out of stock |
Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.
shop the compounds →Frequently asked questions about 5-Amino-1MQ and Cagrilintide
What is 5-Amino-1MQ?
5-Amino-1MQ is a small molecule, not a peptide — a methylquinolinium compound that selectively inhibits the enzyme nicotinamide N-methyltransferase (NNMT). Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
Is 5-Amino-1MQ a peptide?
No. It is a small-molecule enzyme inhibitor with no amino-acid backbone, which is why it is handled and stored differently from the peptides in the catalog. It is supplied strictly for laboratory research.
What is Cagrilintide?
Cagrilintide is a synthetic long-acting analog of the pancreatic peptide amylin, engineered for stability and extended half-life. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is Cagrilintide studied for in research?
It is used as a reference agonist in amylin- and calcitonin-receptor pharmacology, RAMP-complex research, and metabolic-signaling models in vitro and pre-clinically. Verve makes no health claims.
related comparisons
verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.